This review considers some aspects of the biochemistry of beta-amyloid, a p
rotein which produces insoluble deposits in the brain. These deposits are a
specific morphological feature of Alzheimer's disease, Down's syndrome, an
d senile dementia. Our contribution. to the concept of a soluble form of be
ta-amyloid as of a normal human protein is presented.